Last updated 31 days ago

A Study to Evaluate Change in Disease Activity of Subcutaneous (SC) Epcoritamab Combined With Intravenous and Oral Rituximab, Cyclophosphamide, Doxorubicin Hydrochloride, Vincristine, and Prednisone (R-CHOP) or R-CHOP in Adult Participants With Newly Diagnosed Diffuse Large B-Cell Lymphoma (DLBCL)

900 patients around the world
Available in United States, Brazil
AbbVie
6Research sites
900Patients around the world
This study is for people with
Non-Hodgkin Lymphoma
Large B-cell lymphoma
Requirements for the patient
To 79 Years
All Gender
Medical requirements
Sites
AC Camargo Cancer Center
Recruiting
São Paulo, 01509-001
Beneficência Portuguesa de São Paulo
Recruiting
R. Maestro Cardim, 637 - Bela Vista, São Paulo - SP, 01323-001
Hospital Alemão Oswaldo Cruz
Recruiting
R. Treze de Maio, 1815 - Bela Vista, São Paulo - SP, 01323-020, Brazil
Hospital das Clínicas da Faculdade de Medicina da São Paulo - USP
Recruiting
Rua Dr. Ovídio Pires de Campos 785 - Estado de São Paulo 05403-000
Hospital Amaral Carvalho
Recruiting
R. Doná Silvéria, 150 - Chácara Braz Miraglia, Jaú - SP, 17210-080, Brazil
Fundação Antônio Prudente - CAPEC - Centro de Apoio à Pesquisa Clínica
Recruiting
R. Prof. Antônio Prudente, 212 - Liberdade, São Paulo - SP, 01509-010
Trialtech
About usOur missionOur teamPartnersFAQs
Medical newsLatest newsStudiesInterviewsTestimonials
ProductsUEPM OncoUEPM Physicians
LinksDownloads
LinkedinInstagramFacebook
Terms and ConditionsPrivacy Policy